Analysis of Blood Serum by the Method of Refractometry in Antitumor Therapy in Patients with Multiple Myeloma
The serum of patients with multiple myeloma was examined by refractometric methods before and after the course of antitumor therapy. It was found that the amount of protein in the serum of patients with multiple myeloma, determined by the value of the serum refractive index, tended to decrease after the course of treatment. The value of the refractive index of blood serum can be used as an additional criterion for assessing the dynamics of changes in blood-serum properties during antitumor therapy.
Unable to display preview. Download preview PDF.
- 1.Multiple Myeloma. Diagnosis and Treatment, Ed. by M. A. Gertz and S. V. Rajkumar (Springer, New York, 2014). doi 10.1007/978-1-4614-8520-9Google Scholar
- 2.Handbook of Multiple Myeloma, Ed. by M. Mohty and J.-L. Harousseau (Adis, 2015).Google Scholar
- 3.L. Plotnikova, A. M. Polyanichko, M. Kobeleva, M. Uspenskaya, A. Garifullin, and S. Voloshin, J. Phys.: Conf. Ser. 784, 012047 (2017).Google Scholar
- 5.B. M. Stifatov and Yu. V. Rublinetskaya, Refractometry, Methodical Instructions (Samar. Gos. Tekh. Univ., Samara, 2013) [in Russian].Google Scholar
- 6.S. V. Lelevich, I. A. Kurstak, T. N. Grinevich, and V. V. Vorob’ev, Principles of Clinical Biochemistry, The School-Book (Grodnen, Gos. Med. Univ., Grodno, 2013) [in Russian].Google Scholar
- 7.S. S. Bessmel’tsev, Klin. Onkogematol. 6, 379 (2013).Google Scholar